Abstract:
Methods to ameliorate cardiac conditions using PGF analogs which lack affinity for prostaglandin receptors is disclosed. Systemic administration of at least one PGF analog, preferably unoprostone isopropyl ester provides both therapeutic and prophylactic treatment for such conditions as congestive heart failure.